Skip to main content
. 2010 Jan;2(1):a001008. doi: 10.1101/cshperspect.a001008

Figure 1.

Figure 1.

TP53 mutations prevalence in sporadic cancers. The proportion of tumors with somatic TP53 mutations is indicated. Data from IARC TP53 Database (R13, November 2008)(Petitjean et al. 2007b).